Fluidigm Corporation (NASDAQ:FLDM) today announced that Chief Executive
Officer and President Gajus Worthington will present at the 33rd Annual
J.P. Morgan Healthcare Conference in San Francisco, on Thursday, January
15, 2015 at 8:30 a.m. (PT).
Audio of Fluidigm’s presentation will be webcast at:
http://jpmorgan.metameetings.com/confbook/healthcare15/directlink?p=17204.
The webcast will be archived for 90 days following the live presentation.
About Fluidigm
Fluidigm (NASDAQ:FLDM) develops, manufactures, and markets life science
analytical and preparatory systems for growth markets such as
single-cell biology and production genomics. We sell to leading academic
institutions, clinical laboratories, and pharmaceutical, biotechnology,
and agricultural biotechnology companies worldwide. Our systems are
based on proprietary microfluidics and multi-parameter mass cytometry
technology, and are designed to significantly simplify experimental
workflow, increase throughput, and reduce costs, while providing
excellent data quality. Fluidigm products are provided for Research Use
Only. Not for use in diagnostic procedures.
For more information, please visit www.fluidigm.com.
Fluidigm and the Fluidigm logo are trademarks or registered trademarks
of Fluidigm Corporation.
Copyright Business Wire 2015